Craft.co Announces Five Year, $28 Million Contract with Secretary of the Air Force for Supplier Risk and Intelligence Technology
06 mai 2024 06h00 HE
|
Craft
SAN FRANCISCO, May 06, 2024 (GLOBE NEWSWIRE) -- Craft.co (www.craft.co), the supply chain resilience company, today announced a $28 million, five-year agreement with the Secretary of the Air Force...
Oscilla Power Successfully Launches Demonstration Scale TritonTM Wave Energy Converter (WEC) on Maine Coast
05 déc. 2023 09h30 HE
|
Oscilla Power
A 1/6 scale of Oscilla Power's 1 MW wave energy converter was successfully deployed off the coast of Maine for a 12-week test.
Ocean Biomedical (NASDAQ: OCEA) Announces First Patients Dosed by Joint Venture Partner Virion Therapeutics in Phase 1b Study of Novel Immunotherapy for Chronic Hepatitis B Virus Infection
26 oct. 2023 05h30 HE
|
Ocean Biomedical, Inc.
Providence, RI, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...
Taglich Brothers Initiates Coverage of Ocean Biomedical, Inc.
31 mai 2023 09h30 HE
|
Taglich Brothers Inc
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of Ocean Biomedical, Inc. (NASDAQ: OCEA). Ocean Biomedical, Inc. headquartered in...
Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%
23 févr. 2023 08h01 HE
|
Ocean Biomedical, Inc.
Providence, RI, Feb. 23, 2023 (GLOBE NEWSWIRE) -- As previously announced, Ocean Biomedical, Inc. (NASDAQ: OCEA) celebrates the discovery of bispecific antibodies that target Chitinase 3-like-1 and...
Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination
06 févr. 2023 09h15 HE
|
Aesther Healthcare Acquisition Corp.
NEW YORK and PROVIDENCE, R.I, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (“SPAC”) and Ocean Biomedical,...
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.
19 sept. 2022 07h45 HE
|
Aesther Healthcare Acquisition Corp.
NEW YORK and PROVIDENCE, R.I., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) (“Aesther”), a special purpose acquisition company (SPAC) and Ocean Biomedical,...